TRIM33 and cancer: Anti-transcriptional intermediary factor 1γ (anti-TIF1γ) antibody-positive dermatomyositis is a specific subtype of dermatomyositis with an established link to several malignancies, with up to half of adult patients harboring an underlying or concurrent cancer [2].